Roudinah Wail Edrees

Ms. Roudinah Wail Edrees

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Radiography
Verified
Journal Article
Closed access
FAFahad M. Almutairi
Fahad M. Almutairi
AAAli Aldhebaib
Ali Aldhebaib
MWmohammad wazzan
mohammad wazzan
KKKhalid Khashoggi
Khalid Khashoggi
AAA.H. Abduljabar
A.H. Abduljabar
BAB.S. Almutairi
B.S. Almutairi

1 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ABABIR BOUAOUN
ABIR BOUAOUN
RAReem M. Althubaiti
Reem M. Althubaiti
RERoudinah Wail Edrees
Roudinah Wail Edrees
AMAfnan A Malaih
Afnan A Malaih
Background: Although Diagnostic Reference Levels (DRLs) based on anatomical regions are widely used in Computed Tomography (CT) imaging, a clinical-indication-based approach provides a more accurate representation of daily practice and protocol variation. This study aimed to establish typical radiation doses for common CT clinical indications among adult patients at King Abdulaziz University Hospital (KAUH) in Saudi Arabia. Methods: This retrospective cross-sectional study included 298 adult patients who underwent CT examinations between 2020 and 2025 using two dual-source scanners operating in single- and dual-source modes. Demographic data, acquisition parameters, and radiation dose metrics, including volume CT dose index (CTDIvol) and the dose–length product (DLP) were extracted from scanner consoles. Six clinical indications were analyzed: brain trauma, sinusitis, chest metastases (chest Mets), interstitial lung disease (ILD), abdominopelvic metastases (AbdPel Mets), and hernia. Results: Typical median CTDIvol values in mGy were 36.4 for brain trauma, 3.4 for sinusitis, 4.9 for chest Mets, 5.6 for ILD, 7.2 for AbdPel Mets and hernia. Corresponding DLP values in mGy·cm were 654, 50, 173, 188, 344, and 369, respectively. Brain trauma demonstrated the highest radiation exposure, whereas sinusitis CT showed the lowest. Most values were comparable to or lower than international DRLs. Conclusions: This study provides the first comprehensive clinical-indication-based DRL data in Saudi Arabia beyond anatomical benchmarks, supporting ongoing dose optimization and future national DRL development.

18 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ABABIR BOUAOUN
ABIR BOUAOUN
RAReem M. Althubaiti
Reem M. Althubaiti
RERoudinah Wail Edrees
Roudinah Wail Edrees
AMAfnan A Malaih
Afnan A Malaih
Background: Although diagnostic reference levels (DRLs) based on anatomical regions are widely used in computed tomography (CT) imaging, a clinical-indication-based approach provides a more accurate representation of daily practice and protocol variation. This study aimed to establish typical radiation doses for common CT clinical indications among adult patients at King Abdulaziz University Hospital (KAUH) in Saudi Arabia. Methods: This retrospective cross-sectional study included 298 adult patients who underwent CT examinations between 2020 and 2025 using two dual-source scanners operating in single- and dual-source modes. Demographic data, acquisition parameters, and radiation dose metrics, including CT dose index (CTDIvol) and the dose–length product (DLP), were extracted from scanner consoles. Six clinical indications were analyzed: brain trauma, sinusitis, chest metastases (chest Mets), interstitial lung disease (ILD), abdominopelvic metastases (AbdPel Mets), and hernia. Results: Typical median CTDIvol values in mGy were 36.4 for brain trauma, 3.4 for sinusitis, 4.9 for chest Mets, 5.6 for ILD, 7.2 for AbdPel Mets and hernia. Corresponding DLP values in mGy·cm were 654, 50, 173, 188, 344, and 369, respectively. Brain trauma demonstrated the highest radiation exposure, whereas sinusitis CT showed the lowest. Most values were comparable to or lower than international DRLs. Conclusions: This study provides the first comprehensive clinical-indication-based DRL data in Saudi Arabia beyond anatomical benchmarks, supporting ongoing dose optimization and future national DRL development.